Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today is hosting an Investor and Analyst Day ...
Next week brings a series of important economic data points, including the latest readout of the Federal Reserve's preferred inflation gauge. Third-quarter earnings season, meanwhile, is yet to ramp ...